You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company has recently launched its first diagnostic test on the market and is developing a second, which is currently in clinical trials.
In Nature this week: loci linked to major depressive disorder, and more.
With genotypes for hundreds of thousands of individuals, investigators uncovered 15 loci linked to major depressive disorder in individuals with European ancestry.
The firm plans to launch testing in the US this fall through Atlanta-based Alpha Genomix, and is looking for similar partners in Asia for a new Asia-specific panel.
Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals.
The company's test, CNSDose, incorporates multiple genes involved in metabolism of antidepressants in the liver and how they cross into the brain via the blood-brain-barrier.
A genome-wide association study of some 89,000 people linked variants in circadian rhythm genes to being a morning person.
At Quartz, Jennifer Walker discusses the little talked about issue of depression in graduate school.
In Nature this week: two loci linked to depression, CRISPR/Cas9-based study of diarrhea-causing microbe, and more.
The CONVERGE consortium has found two loci, including one near a mitochondrial biogenesis gene, that are associated with major depressive disorder.
Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports.
The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.
Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.
In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.